Grove Biopharma
Founded: 2020
Northwestern Inventor:
Nathan Gianneschi
Weinberg School of Arts and Sciences
Department of Chemistry
Grove Biopharma is a biotechnology company pioneering its proprietary Bionic Biologics(TM) platform to develop novel therapies targeting intracellular protein-protein interaction. Bionic Biologics represent a novel therapeutic modality that integrates principles of biologic and synthetic design. This innovative platform enables the targeting of well-validated yet previously intractable disease drivers, unlocking new possibilities for therapeutic intervention. A spinout from Northwestern University, Grove brings together a multidisciplinary team of chemists, biologists, materials scientists and entrepreneurs.